Extraintestinal manifestations in Korean patients with inflammatory bowel disease: A nationwide population-based study from 2005 to 2017
- 30 April 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 32 (9) , 1760-1769
Abstract
Background: Extraintestinal manifestations (EIMs) significantly contribute to morbidity in individuals with inflammatory bowel disease (IBD); however, population-based East Asian data remain limited. We evaluated EIM burden in a nationwide Korean IBD cohort. Methods: This nationwide retrospective cohort study was conducted using data from the Korean National Health Insurance Service between 2005 and 2017. Individuals with ulcerative colitis (UC) or Crohn’s disease (CD) were identified using the International Classification of Diseases–10th Edition and rare intractable disease codes. EIM incidence, associated risk factors, interval from IBD diagnosis to EIM onset, and trends by sex and age were examined. Results: Among 69 414 individuals with IBD (48 689 UC, 20 725 CD), 42.23% developed at least 1 EIM. Dermatologic manifestations were the most common (17.02%), followed by musculoskeletal (16.36%), hepatopancreaticobiliary (15.48%), and ophthalmologic (7.83%) manifestations. Low socioeconomic status, smoking history, female sex, and higher Charlson Comorbidity Index scores independently correlated with EIM development in UC (hazard ratios of 2.14, 1.18, 1.15, and 1.08, respectively) and CD (hazard ratios of 1.98, 1.20, 1.18, and 1.09, respectively). Most EIMs developed within 4 to 6 years postdiagnosis, with musculoskeletal EIMs occurring earliest (median 42.9 months [interquartile range: 10.3-89.5 months]). Annual EIM incidence increased steadily over time across all age groups. Conclusions: EIMs affected 42.23% of Korean individuals with IBD, most frequently appearing 4 to 6 years postdiagnosis. Low socioeconomic status, smoking history, female sex, and higher Charlson Comorbidity Index scores consistently correlated with EIM occurrence, and incidence increased steadily over time, highlighting the need for sustained, personalized monitoring and timely intervention.Keywords
Funding Information
- Hanyang University Research Fund (HY-202300000003499)
- Hanyang University Research Fund (HY-202000000003333)
This publication has 28 references indexed in Scilit:
- Prevalence, Clinical Features, and Extraintestinal Manifestations in Patients with Familial Inflammatory Bowel DiseasesDigestive Diseases and Sciences, 2025
- Smoking changes adaptive immunity with persistent effectsNature, 2024
- Extraintestinal manifestation of inflammatory bowel disease in Asian patients: A multinational studyDigestive and Liver Disease, 2021
- Socioeconomic status and inflammation: a meta-analysisMolecular Psychiatry, 2018
- Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studiesThe Lancet, 2017
- Estrogen receptors regulate innate immune cells and signaling pathwaysCellular Immunology, 2015
- Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease CohortAmerican Journal of Gastroenterology, 2011
- Extraintestinal manifestations of inflammatory bowel diseaseDigestive and Liver Disease, 2008
- Inflammatory bowel disease: clinical aspects and established and evolving therapiesThe Lancet, 2007
- Socioeconomic status and health: The challenge of the gradient.American Psychologist, 1994